| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/26/1997 | DE19549286A1 Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 06/26/1997 | DE19548114A1 Konjugat, umfassend einen Wirkstoff, ein Polypeptid und einen Polyether A conjugate comprising an active substance, a polypeptide and a polyether |
| 06/25/1997 | EP0779933A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 06/25/1997 | EP0779821A1 Improvements in or relating to contrast agents |
| 06/25/1997 | CN1152925A Monoclonal antibody active against CD44V6 |
| 06/25/1997 | CN1152880A Diagnostic image analysis with metal complexes |
| 06/25/1997 | CN1152869A Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/24/1997 | US5641878 Labeled marker component comprising fluorophore coupled to solubilizing polyoxyhydrocarbyl moieties |
| 06/24/1997 | US5641746 Inducing aids symptoms in animals by administering peptide t, vip, or glycoprotein 120 |
| 06/24/1997 | US5641472 Tungsten clusters |
| 06/18/1997 | EP0778849A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/17/1997 | US5639656 Antibodies reactive with biological markers of benign prostate hyperplasia |
| 06/17/1997 | US5639617 Determining concentration of procalcitonin in biological fluids to diagnose infections or monitor treatment |
| 06/17/1997 | US5639601 Synthetic peptide sequences useful in detection of foot and mouth disease |
| 06/17/1997 | US5639473 Subjecting aqueous medium containing biocompatible material capable of being crosslinked by disulfide bonds and nucleic acid construct to high intensity ultrasound waves |
| 06/17/1997 | US5639444 Administering contrast agents |
| 06/17/1997 | US5639443 Stabilized microbubble compositions |
| 06/17/1997 | US5639442 Contrast media for ultrasonic imaging |
| 06/17/1997 | US5639441 Dissolving substance to form solution, mixing with fluid which forms gas on rapid depressurization, depressurization |
| 06/12/1997 | WO1997020841A2 New macrobicyclic compounds, methods of preparing them and pharmaceutical agents containing them |
| 06/11/1997 | EP0777706A1 High purity ferromagnetic iron oxide pigments |
| 06/11/1997 | EP0777500A1 Oral contrast agent for ultrasound diagnostic procedures |
| 06/11/1997 | EP0777497A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | CN1151702A Low viscosity chelating polymers |
| 06/11/1997 | CN1151701A Cascade-polymer complexes and method of producing the same |
| 06/10/1997 | US5637759 Magnetic resonance imaging; solid phase biosynthesis; chelate compounds |
| 06/10/1997 | US5637289 Carbohydrate microparticles mixed with less water soluble compound |
| 06/10/1997 | US5637288 Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
| 06/05/1997 | WO1997019938A1 Fluorescent derivatives of paclitaxel and docetaxel with antineoplastic activity, method for producing them and their applications |
| 06/05/1997 | WO1997003704A3 In vivo diabetes test |
| 06/04/1997 | EP0776362A1 Method for preparing an influenza virus, antigens obtained and applications thereof |
| 06/04/1997 | EP0776219A2 Compositions |
| 06/04/1997 | EP0526503B1 Polymers as contrast media for magnetic resonance imaging |
| 06/04/1997 | CN1150947A Alkenyl-benzoyl guanidine derivant |
| 06/03/1997 | US5635603 Antibody fragment covalently bound to diagnostic or therapeutic principle through carbohydrate moiety |
| 06/03/1997 | US5635400 Minimally cross-hybridizing sets of oligonucleotide tags |
| 06/03/1997 | US5635382 Method for enhancing transmembrane transport of exogenous molecules |
| 06/03/1997 | US5635215 Hydrophilic acrylic copolymer coated with cell adhesion promoter |
| 06/03/1997 | US5635207 Subjecting aqueous medium containing oxygen binding protein to high intensity ultrasound conditions to promote crosslinking and form polymeric shell of specified size |
| 06/03/1997 | US5635158 Peptides modified by the phosphine group for marking with 99M TC and 186-188 RE or paramagnetic agents |
| 05/29/1997 | WO1997018841A1 Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/29/1997 | WO1997005906A3 Diagnostic and diagnosis method for central nervous abnormality and phenylketonuria |
| 05/28/1997 | EP0775151A2 Sialic acid/fucose based medicaments |
| 05/28/1997 | EP0775117A1 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells |
| 05/28/1997 | EP0775104A1 Dimer dtpa derivatives and their metal complexes, pharmaceuticals containing the same, their use in diagnosis and therapy and process for preparing said complexes and pharmaceuticals |
| 05/28/1997 | EP0774970A1 Method of using hyaluronic acid for the detection, location and diagnosis of tumors |
| 05/28/1997 | EP0650473B1 Radioimaging and radiochemotherapy phenolic thioether amines and acyl derivatives thereof for use in diagnosing and treating pigmentation disorders |
| 05/28/1997 | EP0472522B1 Method for screening cells or formed bodies with populations expressing selected characteristics |
| 05/28/1997 | EP0418335B1 Process for the evaluation of the anti-oxidant activity of a chemical or physical agent by means of free radicals |
| 05/28/1997 | DE19543077A1 Verwendung von gashaltigen Metallkomplexen als Ultraschallkontrastmittel Use of gas-containing metal complexes as ultrasound contrast agents |
| 05/28/1997 | CN1150761A Delivery of therapeutic agents to receptors using polysaccharides |
| 05/27/1997 | US5633372 Heterocycle based nitrogen sulfur ligands useful in radiographic imaging agents |
| 05/27/1997 | US5632970 Fluoresence detection using texaphyrins |
| 05/22/1997 | WO1997018300A2 Murine model for human carcinoma |
| 05/22/1997 | WO1997018231A1 Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 05/22/1997 | WO1997018207A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 05/22/1997 | WO1997017995A2 Use of gaseous metallic complexes as ultrasound contrasting agents |
| 05/22/1997 | WO1997001359A3 Metal complexes of polyaminoacids, and their utilization in diagnostic imaging |
| 05/22/1997 | DE19542692A1 Elimination of X=ray contrast agents from clinical waste water |
| 05/22/1997 | CA2237524A1 Novel macrocyclic compounds as metalloprotease inhibitors |
| 05/22/1997 | CA2237394A1 Use of gaseous metallic complexes as ultrasound contrasting agents |
| 05/21/1997 | EP0773936A1 Macrocyclic chelants, their chelates and uses thereof in the diagnostic field |
| 05/21/1997 | EP0773798A1 Contrast mediums for use in imaging the liver |
| 05/21/1997 | EP0773796A1 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
| 05/21/1997 | CN1150391A Dendrimeric compounds |
| 05/20/1997 | US5631407 Testing the efficacy of a vaccine to determine protection from infection by human picornavirus; genetic engineering |
| 05/20/1997 | US5631172 Lead assay |
| 05/20/1997 | US5630997 Contrast agents for nuclear magnetic resonance imaging of liver and gastrointestinal system |
| 05/15/1997 | WO1997017091A1 Guinea pig model for leiomyomas and atherosclerosis |
| 05/15/1997 | WO1997012551A3 Improvements in or relating to ultrasound imaging |
| 05/15/1997 | CA2235036A1 Guinea pig model for leiomyomas and atherosclerosis |
| 05/14/1997 | EP0772776A1 Superparamagnetic particles, process for their production and their use |
| 05/14/1997 | EP0772628A1 Peptide derived radionuclide chelators |
| 05/14/1997 | EP0772458A1 Use of chelates as x-ray contrast mediums |
| 05/14/1997 | EP0772457A1 Diatrizoxy ester as x-ray contrast agents for imaging the blood pool and lymphatic system |
| 05/14/1997 | CN1149494A X-ray colon special double-contrast contrast medium |
| 05/13/1997 | US5629166 Cancer diagnosis |
| 05/13/1997 | US5628983 Squid magnetometry using paramagnetic metal chelates |
| 05/13/1997 | US5628982 Metal is gadolinium, iron, manganese, chromium, copper, dysprosium, terbium, holmium, erbium or europium; ligand is linear two-nitrogen compound with 2-hydroxyaryl group at a nitrogen; enhanced contrast in the imaging |
| 05/13/1997 | US5628981 Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents |
| 05/13/1997 | US5628980 Nonionic radiographic contrast agents |
| 05/09/1997 | WO1997016474A1 Targeted magnetically labeled molecular marker systems for the nmr imaging |
| 05/07/1997 | EP0771208A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 05/07/1997 | CN1149259A Stabilized homogenous suspensions AS computed tomography contrast agents |
| 05/06/1997 | USRE35500 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/06/1997 | US5627050 Bone-related sulfatase-like protein and process for its production |
| 05/06/1997 | US5627036 Use of an anticoagulant as a diagnostic agent |
| 05/06/1997 | US5626833 Enhancing ultrasound contrast |
| 05/06/1997 | US5626832 Iodinated contrast agent |
| 05/02/1997 | EP0770627A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 05/02/1997 | EP0770352A1 Ultrasonic diagnostic imaging with contrast agents |
| 05/02/1997 | EP0770146A1 Conjugates of metal complexes and oligonucleotides, which specifically bond to specific target structures, agents containing these conjugates, their use in nmr diagnosis as well as process for their production |
| 05/02/1997 | EP0769969A1 Gas-filled microspheres with fluorine-containing shells |
| 05/02/1997 | EP0769967A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 05/02/1997 | EP0769966A1 Biotin compounds for targetting tumors and sites of infection |
| 05/02/1997 | EP0769958A1 Inhibitors of leukocyte adhesion |
| 05/01/1997 | WO1997015668A2 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 05/01/1997 | WO1996040277A3 Spray dried polymeric microparticles containing imaging agents |
| 04/30/1997 | CN1148813A Contrast medium |